Article thumbnail

Short Telomeres Compromise β-Cell Signaling and Survival

By Nini Guo, Erin M. Parry, Luo-Sheng Li, Frant Kembou, Naudia Lauder, Mehboob A. Hussain, Per-Olof Berggren and Mary Armanios

Abstract

The genetic factors that underlie the increasing incidence of diabetes with age are poorly understood. We examined whether telomere length, which is inherited and known to shorten with age, plays a role in the age-dependent increased incidence of diabetes. We show that in mice with short telomeres, insulin secretion is impaired and leads to glucose intolerance despite the presence of an intact β-cell mass. In ex vivo studies, short telomeres induced cell-autonomous defects in β-cells including reduced mitochondrial membrane hyperpolarization and Ca2+ influx which limited insulin release. To examine the mechanism, we looked for evidence of apoptosis but found no baseline increase in β-cells with short telomeres. However, there was evidence of all the hallmarks of senescence including slower proliferation of β-cells and accumulation of p16INK4a. Specifically, we identified gene expression changes in pathways which are essential for Ca2+-mediated exocytosis. We also show that telomere length is additive to the damaging effect of endoplasmic reticulum stress which occurs in the late stages of type 2 diabetes. This additive effect manifests as more severe hyperglycemia in Akita mice with short telomeres which had a profound loss of β-cell mass and increased β-cell apoptosis. Our data indicate that short telomeres can affect β-cell metabolism even in the presence of intact β-cell number, thus identifying a novel mechanism of telomere-mediated disease. They implicate telomere length as a determinant of β-cell function and diabetes pathogenesis

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3053388
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2003). A DNA damage checkpoint response in telomere-initiated senescence.
  2. (2007). A genomewide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
  3. (1999). A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse.
  4. (1988). A novel gene activated in regenerating islets.
  5. (2009). A protocol for islet isolation from mouse pancreas.
  6. (1989). A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis.
  7. (2008). Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretion.
  8. (2004). Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.
  9. (2009). Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation.
  10. (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
  11. Cholinergic augmentation of insulin release requires ankyrin-B.
  12. (2008). Clinical risk factors, DNA variants, and the development of type 2 diabetes.
  13. (1992). Dyskeratosis congenita associated with elevated fetal hemoglobin, X-linked ocular albinism, and juvenile-onset diabetes mellitus.
  14. (1972). Dyskeratosis congenita: relationship to Fanconi’s anemia.
  15. (1998). Essential role of mouse telomerase in highly proliferative organs.
  16. (2006). Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice.
  17. (1999). Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.
  18. (2004). frequency and insulin exocytosis.
  19. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes.
  20. (2007). Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.
  21. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
  22. (2005). Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.
  23. (2000). Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes.
  24. (2007). Insulin gene mutations as a cause of permanent neonatal diabetes.
  25. (2006). Islet beta cell failure in type 2 diabetes.
  26. (2009). Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction.
  27. (2006). Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes.
  28. (2008). National diabetes fact sheet: general information and national estimates on diabetes in the United States,
  29. (2006). p16INK4a induces an age-dependent decline in islet regenerative potential.
  30. (2007). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
  31. (2009). Role of diabetes mellitus and gastrooesophageal reflux in the aetiology of idiopathic pulmonary fibrosis.
  32. (2003). Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea.
  33. (2003). Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci.
  34. (2008). Short telomeres are a risk factor for idiopathic pulmonary fibrosis.
  35. (2009). Short telomeres are sufficient to cause the degenerative defects associated with aging.
  36. (2005). Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
  37. (2004). Spectral analysis of calcium oscillations. Sci STKE 2004: pl15. Short Telomeres Compromise b-Cell Function PLoS
  38. (2003). Summaries of Affymetrix GeneChip probe level data.
  39. (2009). Syndromes of telomere shortening.
  40. (2002). Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes.
  41. Telomerase deficiency impairs glucose metabolism and insulin secretion. Aging
  42. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.
  43. (2008). Telomere shortening in familial and sporadic pulmonary fibrosis.
  44. (2005). Telomere shortening occurs in Asian Indian Type 2 diabetic patients.
  45. (1990). Telomeres shorten during ageing of human fibroblasts.
  46. (2001). The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.
  47. (2006). The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology.
  48. (2001). The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability.
  49. (1987). The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity.